International Waldenstrom's Macroglobulinemia Foundation (IWMF)
Latest Content
The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.
Advertisement
Advertisement
Trending on CURE
1
From Stage 4 to Survivor: Dan’s Pancreatic Cancer Journey
2
Radiation Plus Keytruda Before Surgery Boosts Immune Response in Breast Cancer
3
Acupuncture Improves Cognitive Function in Breast Cancer Survivors
4
Rising Lung Cancer Rates Targets Asian Women Nonsmokers in California
5
